|
1
|
Emile JF, Azoulay D, Gornet JM, Lopes G,
Delvart V, Samuel D, Reynès M, Bismuth H and Goldwasser F: Primary
non-Hodgkin's lymphomas of the liver with nodular and diffuse
infiltration patterns have different prognoses. Ann Oncol.
12:1005–1010. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nguyen GK: Primary extranodal
non-Hodgkin's lymphoma of the extrahepatic bile ducts. Report of a
case. Cancer. 50:2218–2222. 1982.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Joo YE, Park CH, Lee WS, Kim HS, Choi SK,
Cho CK, Rew JS, Kim SJ and Maetani I: Primary non-Hodgkin's
lymphoma of the common bile duct presenting as obstructive
jaundice. J Gastroenterol. 39:692–696. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yoon MA, Lee JM, Kim SH, Lee JY, Han JK,
Choi BI, Kim SW and Jang JJ: Primary biliary lymphoma mimicking
cholangiocarcinoma: A characteristic feature of discrepant CT and
direct cholangiography findings. J Korean Med Sci. 24:956–959.
2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wu J, Zhou Y, Li Q, Zhang J and Mao Y:
Primary biliary non-Hodgkin's lymphoma: A case report. Medicine
(Baltimore). 100(e26110)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gallamini A and Juweid M (eds): Lymphoma.
Exon Publications, Brisbane, AU, 2021.
|
|
7
|
Hans CP, Weisenburger DD, Greiner TC,
Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E,
Braziel RM, Jaffe ES, et al: Confirmation of the molecular
classification of diffuse large B-cell lymphoma by
immunohistochemistry using a tissue microarray. Blood. 103:275–282.
2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sehn LH, Berry B, Chhanabhai M, Fitzgerald
C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J,
et al: The revised international prognostic index (R-IPI) is a
better predictor of outcome than the standard IPI for patients with
diffuse large B-cell lymphoma treated with R-CHOP. Blood.
109:1857–1861. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lokich JJ, Kane RA, Harrison DA and
McDermott WV: Biliary tract obstruction secondary to cancer:
Management guidelines and selected literature review. J Clin Oncol.
5:969–981. 1987.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ravindra KV, Stringer MD, Prasad KR,
Kinsey SE and Lodge JP: Non-Hodgkin lymphoma presenting with
obstructive jaundice. Br J Surg. 90:845–849. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
André SB, Farias AQ, Bittencourt PL,
Guarita DR, Machado MC, Viana R and Laudanna AA: Primary extranodal
non-Hodgkin lymphoma of the extrahepatic bile duct mimmicking
Klatskin tumor. Rev Hosp Clin Fac Med Sao Paolo. 51:192–194.
1996.PubMed/NCBI
|
|
12
|
Das K, Fisher A, Wilson DJ, dela Torre AN,
Seguel J and Koneru B: Primary non-Hodgkin's lymphoma of the bile
ducts mimicking cholangiocarcinoma. Surgery. 134:496–500.
2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Odemiş B, Parlak E, Başar O, Yüksel O and
Sahin B: Biliary tract obstruction secondary to malignant lymphoma:
Experience at a referral center. Dig Dis Sci. 52:2323–2332.
2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Noronha V, Shafi NQ, Obando JA and Kummar
S: Primary non-Hodgkin's lymphoma of the liver. Crit Rev Oncol
Hematol. 53:199–207. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dlouhy I, Filella X, Rovira J, Magnano L,
Rivas-Delgado A, Baumann T, Martínez-Trillos A, Balagué O, Martínez
A, González-Farre B, et al: High serum levels of soluble
interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor
necrosis factor alpha (TNF) are associated with adverse clinical
features and predict poor outcome in diffuse large B-cell lymphoma.
Leuk Res. 59:20–25. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fritscher-Ravens A, Broering DC, Sriram
PV, Topalidis T, Jaeckle S, Thonke F and Soehendra N: EUS-guided
fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a
case series. Gastrointest Endosc. 52:534–540. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kosuge T, Makuuchi M, Ozaki H, Kinoshita
T, Takenaka T and Mukai K: Primary lymphoma of the common bile
duct. Hepatogastroenterology. 38:235–238. 1991.PubMed/NCBI
|
|
18
|
Maymind M, Mergelas JE, Seibert DG,
Hostetter RB and Chang WW: Primary non-Hodgkin's lymphoma of the
common bile duct. Am J Gastroenterol. 92:1543–1546. 1997.PubMed/NCBI
|
|
19
|
Luigiano C, Ferrara F, Fabbri C, Ghersi S,
Bassi M, Polifemo AM, Billi P, Fornelli A, Cinquantini F and
D'Imperio N: Primary lymphoma of the common bile duct presenting
with acute pancreatitis and cholangitis. Endoscopy. 42 (Suppl
2):E265–E266. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
International Non-Hodgkin's Lymphoma
Prognostic Factors Project. A predictive model for aggressive
non-Hodgkin's lymphoma. N Engl J Med. 329:987–994. 1993.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Coiffier B, Lepage E, Briere J, Herbrecht
R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G,
Gaulard P, et al: CHOP chemotherapy plus rituximab compared with
CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
N Engl J Med. 346:235–242. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dudgeon DJ and Brower M: Primary
chemotherapy for obstructive jaundice caused by intermediate-grade
non-Hodgkin lymphoma. Cancer. 71:2813–2816. 1993.PubMed/NCBI View Article : Google Scholar
|
